AIM
ZBH icon

Acrospire Investment Management’s Zimmer Biomet ZBH Stock Holding History

Acrospire Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-556
Closed -$69K – 1471
2017
Q2 		$69K Buy
556
+309
+125% +$36.6K 0.06% 547
2017
Q1 		$29K Sell
247
-618
-71% -$70K 0.02% 1382
2016
Q4 		$87K Sell
865
-165
-16% -$17.7K 0.04% 1030
2016
Q3 		$130K Buy
+1,030
New +$127K 0.09% 356

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acrospire Investment Management's ZBH Position: Q3 2017 in Review

Acrospire Investment Management sold out of Zimmer Biomet (ZBH) in Q3 2017, closing a stake of 556 shares — an estimated $69K sold.

Acrospire Investment Management first reported a position in ZBH in Q3 2016 and held it in 4 quarters. The position peaked at $130K in Q3 2016. 818 funds tracked by Wall St. Rank hold ZBH as of Q3 2017.

  • Acrospire Investment Management reported no remaining Zimmer Biomet position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 556 Zimmer Biomet shares in Q3 2017, an estimated $69K.
  • Acrospire Investment Management first reported a position in Zimmer Biomet in Q3 2016 and held it in 4 quarters.
  • Acrospire Investment Management's Zimmer Biomet position peaked at $130K in Q3 2016.
  • 818 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.